|
| Penicillin | Mono-bactam | Cephamycin | 3rd Gen cephalosporins | Carbapenems | |||||||||||
| N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | ||
| Gender | Male | 13 (61.90) | 2.15 | 0.40 | 6 (35.29) | 1.22 | 0.79 | 1 (100) | - | - | 4 (40.00) | 1.55 | 0.58 | 0 | - | - |
| Female | 8 (38.10) | R | - | 11 (64.71) | R | - | 0 | - | - | 6 (60.00) | R | - | 0 | - | - | |
| Residence | MN | 18 (85.71) | - | - | 14 (82.35) | - | - | 1 (100) | - | - | 8 (80) | - | - | 0 | - | - |
| MR | 1 (4.70) | - | - | 1 (5.88) | - | - | 0 | - | - | 0 | - | - | 0 | - | - | |
| VU | 2 (9.52) | - | - | 2 (11.77) | - | - | 0 | - | - | 2 (20) | - | - | 0 | - | - | |
| Age category | 0 - 50 | 17 (80.95) | - | - | 13 (76.47) | - | - | 0 | - | - | 6 (60) | - | - | 0 | - | - |
| 51 - 100 | 2 (9.52) | - | - | 2 (11.76) | - | - | 1 (100) | - | - | 2 (20) | - | - | 0 | - | - | |
| 101 - 150 | 2 (9.52) |
| - | 2 (11.76) | - | - | 0 | - | - | 2 (20) | - | - | 0 | - | - | |
| 151 - 200 | 0 | - | - | 0 | - | - | 0 | - | - | 0 | - | - | 0 | - | - | |
| Symptoms | D | 13 (61.90) | 0.81 | 0.80 | 12 (70.59) | 2.05 | 0.35 | 1 (100) | - | - | 9 (90) | 9 | 0.55 | 0 | - | - |
| ND | 8 (38.10) | R | - | 5 (29.41) | R | - | - | - | - | 1 (10) | R | - | 0 | - | - | |